{"transactions":[{"id":4623247,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-21T20:20:46.000Z","date":"2026-09-17","kind":"grant","planned":false,"acquired":true,"price":0,"reported_value":12200,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of this option vests on the date of grant and the remaining 50% vests in substantially equal monthly installments over a 12-month period, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":12200,"derivative":{"exercise_price":2.13,"expiration_date":"2036-09-16","underlying":"Common Stock","underlying_shares":12200},"source":{"system":"sec-edgar","filing":"0001140361-26-037245","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000114036126037245/form4.xml","form_type":"4"}},{"id":940923,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T21:01:33.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vests on the date of grant and the remaining 75% vests in substantially equal monthly installments on the 30th day of each month until September 30, 2026, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":3.8,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-26-000966","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000114036126000966/form4.xml","form_type":"4"}},{"id":1150748,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-13T21:21:13.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of this option vests on the date of grant and the remaining 50% vests in substantially equal monthly installments on the 30th day of each month until September 30, 2025, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":2.72,"expiration_date":"2035-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-25-018695","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000114036125018695/form4.xml","form_type":"4"}},{"id":1703283,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-20T21:06:02.000Z","date":"2023-12-19","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which 10,000 shares vest in equal monthly installments over a period of 12 months (provided that 3/12 of the options shall be deemed to have vested upon the date of grant), and 12,500 shares vest in equal quarterly installments over a period of 18 months (Provided that 1/6 of the options shall be deemed to have vested upon the date of grant)."}],"balance_after":22500,"derivative":{"exercise_price":2.125,"expiration_date":"2033-12-19","underlying":"Class A Common Shares","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-23-071877","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000095017023071877/ownership.xml","form_type":"4"}},{"id":2679350,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-07T12:41:13.000Z","date":"2021-06-04","kind":"purchase","acquired":true,"shares":5000,"price":9.89,"value":49450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.75 to\n$9.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in\nthis footnote."}],"balance_after":12900,"source":{"system":"sec-edgar","filing":"0001209191-21-038480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919121038480/doc4.xml","form_type":"4"}},{"id":2813617,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-03T22:05:41.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total shares subject to the option shall vest on March 1, 2022 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":65000,"derivative":{"exercise_price":14.32,"expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-21-016997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919121016997/doc4.xml","form_type":"4"}},{"id":3055947,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-17T20:38:17.000Z","date":"2020-08-13","kind":"purchase","acquired":true,"shares":7900,"price":6.24,"value":49296.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.19 to\n$6.27 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this\nfootnote."}],"balance_after":7900,"source":{"system":"sec-edgar","filing":"0001209191-20-046962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919120046962/doc4.xml","form_type":"4"}},{"id":3238258,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-02T22:46:15.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total shares subject to the option shall vest on February 27, 2021 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":55000,"derivative":{"exercise_price":11.81,"expiration_date":"2030-02-26","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-20-014683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919120014683/doc4.xml","form_type":"4"}},{"id":3390154,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-21T20:49:56.000Z","date":"2019-10-18","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total shares subject to the option shall vest on October 18, 2020 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":125000,"derivative":{"exercise_price":14.65,"expiration_date":"2029-10-18","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-19-053716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919119053716/doc4.xml","form_type":"4"}},{"id":3638410,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-22T08:50:51.000Z","date":"2019-02-20","kind":"grant","acquired":true,"shares":108500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in sixteen equal quarterly installments beginning May 20, 2019, provided the Reporting Person is employed by the Issuer on each vesting date."}],"balance_after":108500,"derivative":{"exercise_price":4.67,"expiration_date":"2029-02-20","underlying":"Common Stock","underlying_shares":108500},"source":{"system":"sec-edgar","filing":"0001179110-19-002285","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1184432/000117911019002285/edgar.xml","form_type":"4"}},{"id":3638409,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-22T08:50:51.000Z","date":"2019-02-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest in full on February 20, 2021, provided the Reporting Person is employed by the Issuer on such date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":33366,"source":{"system":"sec-edgar","filing":"0001179110-19-002285","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184432/000117911019002285/edgar.xml","form_type":"4"}},{"id":4026756,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-02-28T14:37:22.000Z","date":"2018-02-26","kind":"tax_withholding","acquired":false,"shares":8696,"price":6.6,"value":57393.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Strongbridge Biopharma plc to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units."}],"balance_after":13366,"source":{"system":"sec-edgar","filing":"0001179110-18-003028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184432/000117911018003028/edgar.xml","form_type":"4"}},{"id":4073519,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":69510,"kind":"person","name":"DAVIS A BRIAN","position":1,"cik":"0001184432","reported_name":"DAVIS A BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-02-06T16:58:34.000Z","date":"2018-02-05","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in sixteen equal quarterly installments beginning May 5, 2018, provided employee is employed by the Company on each vesting date."}],"balance_after":115000,"derivative":{"exercise_price":6.65,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001179110-18-001636","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184432/000117911018001636/edgar.xml","form_type":"4"}}]}